Invokana and Clopidogrel bisulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invokana (canagliflozin) and Clopidogrel bisulfate (clopidogrel bisulfate). Common drug interactions include dysuria among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Invokana and Clopidogrel bisulfate. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Clopidogrel bisulfate?

Clopidogrel bisulfate has active ingredients of clopidogrel bisulfate. It is often used in blood clots. eHealthMe is studying from 18,075 Clopidogrel bisulfate users. Check the latest studies of Clopidogrel bisulfate.

On Jul, 18, 2026

15 people who take Invokana and Clopidogrel bisulfate together, and have interactions are studied.

Invokana and Clopidogrel bisulfate drug interactions.

What are the common drug interactions of Invokana and Clopidogrel Bisulfate, by gender? *:

female:

Dysuria (painful or difficult urination)
Sluggishness (lacking alertness)
Asthenia (weakness)
Chronic kidney disease
Death
Dizziness
Fall
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

male:

Chronic kidney disease
Diarrhoea
Headache (pain in head)
Hunger
Hyperkalaemia (damage to or disease of the kidney)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Influenza like illness
Memory impairment
Myalgia (muscle pain)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Invokana and Clopidogrel Bisulfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cardiac failure congestive

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Abnormal dreams
Arthralgia (joint pain)
Depression
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Fatigue (feeling of tiredness)
Headache (pain in head)
Hunger
Hyperkalaemia (damage to or disease of the kidney)

60+:

Asthenia (weakness)
Chronic kidney disease
Sluggishness (lacking alertness)
Death
Dizziness
Dysuria (painful or difficult urination)
Fall
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Pancreatitis acute (sudden inflammation of pancreas)

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 26.67%
Hyperkalemia (damage to or disease of the kidney): 3 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Renal Cell Carcinoma (a kidney cancer): 2 people, 13.33%
Heart Attack: 2 people, 13.33%
Depression: 1 person, 6.67%
Diabetes Mellitus Inadequate Control: 1 person, 6.67%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 6.67%
Enlarged Prostate: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and Clopidogrel bisulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously